Outcomes4Me is a 2024 Fast Company World Changing Idea! Learn more >>

Understanding neuropathy nerve damage related to cancer

Shot of an mature man holding his shoulder on a couch

If you’re undergoing cancer treatment, you might experience neuropathy, a type of nerve damage affecting your peripheral nerves. These nerves are essential for transmitting information between your brain, spinal cord, and the rest of your body, and damage to them can lead to a variety of uncomfortable and sometimes debilitating symptoms.

Neuropathy can develop during your cancer treatment and recovery for several reasons. Sometimes, the cancer itself is the culprit; tumors may press against nerves, causing direct damage. More often, however, neuropathy arises as a side effect of cancer treatments. Certain chemotherapy drugs, especially platinum-based medications and taxanes, are known to affect nerve function. Radiation therapy and surgical procedures might also contribute to nerve damage. Additionally, pre-existing conditions like diabetes, vitamin deficiencies, or excessive alcohol consumption can increase your risk of developing neuropathy during treatment.

Understanding the symptoms of neuropathy is crucial for early intervention. You might notice tingling or numbness in your hands and feet, which can progress to a burning or shooting pain. Increased sensitivity to touch or temperature changes is also common. Muscle weakness or cramping may occur, leading to balance issues or difficulty with fine motor skills, such as buttoning a shirt or typing. In some cases, neuropathy can affect autonomic functions, resulting in changes in digestion, blood pressure regulation, or bladder control.

While there is no guaranteed way to prevent neuropathy, proactive management can help alleviate its effects and possibly reduce your risk of developing it. Open communication with your care team is essential. Be proactive in discussing the potential for neuropathy with your oncologist, and report any new or worsening symptoms promptly. Early intervention may help prevent severe nerve damage, allowing your doctors to adjust your treatment plan to minimize further nerve harm.

Consider exploring preventive therapies that show promise in reducing the risk of chemotherapy-induced peripheral neuropathy. Cryotherapy, which involves cooling your hands and feet during chemotherapy infusions, may help reduce nerve damage by constricting blood vessels and limiting the amount of chemotherapy drugs reaching your extremities. Similarly, compression therapy—wearing tight gloves during infusions—might decrease drug exposure to your peripheral nerves. Engaging in regular exercise, particularly activities that improve strength, balance, and general movement at least twice a week, may also lower your risk or severity of side effects from treatment-related neuropathy.

For many cancer patients, neuropathy symptoms improve after treatment concludes. However, some nerve damage might be long-lasting or even permanent. Regardless of the duration, your healthcare team should work closely with you to develop strategies for managing ongoing symptoms and enhancing your quality of life.

_____________________________________

Managing neuropathy can be challenging, but you don’t have to navigate this part of your cancer treatment alone. The Outcomes4Me app is a valuable resource designed to support you every step of the way. By tracking your symptoms over time using the app, you can provide your healthcare team with detailed information that can help inform your neuropathy management plan.

Navigate your cancer journey with confidence

Your cancer experience is unique and so is our app. Here’s why it’s your must-have companion:

  • Get personalized support and treatment options
  • Connect with a community of cancer patients and caregivers
  • Track your symptoms and medications
  • Access the latest cancer research and clinical trials

Download the Outcomes4Me Cancer Care App

Related Articles

If you’re undergoing cancer treatment, you might experience neuropathy, a type of nerve damage affecting...
We were fortunate to host Dr. Martin F. Dietrich, a medical oncologist at the Cancer...